Moreover, public data from Oncomine and TCGA showed that high GCH1 expression correlates with melanoma aggressiveness (Figure S3A), increased expression of PTS (Figure S3B) and SPR (Figure S3C), and decreased GCHFR expression (Figure S3D) in melanoma when compared to benign nevi. The gene discussed is GCH1; the disease is melanoma.